Study of Osteopontin as the “CA125” Adjunct for Detection of Ovarian Carcinoma in Patients with Pelvic Mass

AUTHORS

Malihe Hasanzadeh 1 , Hossein Ayatollahi 2 , Laya Shirinzadeh 3 , Soodabeh Shahidsales 4 , *

1 Women Health Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

2 Cellular-Molecular Pathologic Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

4 Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

How to Cite: Hasanzadeh M, Ayatollahi H, Shirinzadeh L, Shahidsales S. Study of Osteopontin as the “CA125” Adjunct for Detection of Ovarian Carcinoma in Patients with Pelvic Mass, Rep Radiother Oncol. 2013 ; 1(2):e2386.

ARTICLE INFORMATION

Reports of Radiotherapy and Oncology: 1 (2); 59-64
Published Online: September 01, 2013
Article Type: Research Article
Received: June 08, 2013
Accepted: July 28, 2013

Crossmark

CHEKING

READ FULL TEXT
Abstract

Full text is available in the PDF.

Keywords

Ovarian cancer tumor marker diagnosis osteopontin osteoponti CA125

© 0, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

Full text is available in the PDF.

References

  • 1.

    References are available in the PDF.

  • COMMENTS

    LEAVE A COMMENT HERE: